Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Svartberg

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 26, 2003
[Hormonally inactive pituitary adenomas]Morten Lund-Johansen, Sylvi Aanderud, Thomas Schreiner, et al.
Clinical Endocrinology|April 28, 2011
Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cureSven M Carlsen, Johan Svartberg, Thomas Schreiner, et al.
Diabetes Care|December 24, 2009
Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic controlMaria Anita Radtke, Ingrid Nermoen, Magnus Kollind, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 25, 2005
[Primary adrenal failure--causes, diagnostics and therapy]Kristian Løvås, Martina Moter Erichsen, Eystein S Husebye, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2016
Vitamin D 20,000 IU per Week for Five Years Does Not Prevent Progression From Prediabetes to DiabetesRolf Jorde, Stina T Sollid, Johan Svartberg, et al.
European Journal of Endocrinology|November 18, 2008
Normal overall mortality rate in Addison's disease, but young patients are at risk of premature deathMartina M Erichsen, Kristian Løvås, Kristian J Fougner, et al.
The Journal of Clinical Endocrinology and Metabolism|May 22, 2008
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trialSven M Carlsen, Morten Lund-Johansen, Thomas Schreiner, et al.
Diabetes Care|June 21, 2014
No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetesStina Therese Sollid, Moira Y S Hutchinson, Ole M Fuskevåg, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 1, 2006
[Endogenous Cushing's syndrome]Johan Arild Evang, Sven M Carlsen, Johan Svartberg, et al.
Plos One|June 1, 2012
Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø StudyRolf Jorde, Henrik Schirmer, Tom Wilsgaard, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 26, 2003
[Hormonally inactive pituitary adenomas]Morten Lund-Johansen, Sylvi Aanderud, Thomas Schreiner, et al.
Clinical Endocrinology|April 28, 2011
Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cureSven M Carlsen, Johan Svartberg, Thomas Schreiner, et al.
Diabetes Care|December 24, 2009
Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic controlMaria Anita Radtke, Ingrid Nermoen, Magnus Kollind, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 25, 2005
[Primary adrenal failure--causes, diagnostics and therapy]Kristian Løvås, Martina Moter Erichsen, Eystein S Husebye, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2016
Vitamin D 20,000 IU per Week for Five Years Does Not Prevent Progression From Prediabetes to DiabetesRolf Jorde, Stina T Sollid, Johan Svartberg, et al.
European Journal of Endocrinology|November 18, 2008
Normal overall mortality rate in Addison's disease, but young patients are at risk of premature deathMartina M Erichsen, Kristian Løvås, Kristian J Fougner, et al.
The Journal of Clinical Endocrinology and Metabolism|May 22, 2008
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trialSven M Carlsen, Morten Lund-Johansen, Thomas Schreiner, et al.
Diabetes Care|June 21, 2014
No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetesStina Therese Sollid, Moira Y S Hutchinson, Ole M Fuskevåg, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 1, 2006
[Endogenous Cushing's syndrome]Johan Arild Evang, Sven M Carlsen, Johan Svartberg, et al.
Plos One|June 1, 2012
Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø StudyRolf Jorde, Henrik Schirmer, Tom Wilsgaard, et al.
Pageof 7